 Management stage adenocarcinoma prostate Johns Hopkins experience consensus proper management men stage adenocarcinoma prostate cure unlikely many men long intervals free metastatic disease effective palliation local lesion low morbidity desirable consecutive men stage prostate cancer primary modes therapy mean months expectant therapy external beam radiotherapy radical prostatectomy patients homogeneous Gleason grade extent metastatic disease over-all actuarial survival rates radical prostatectomy patients apparent clinical survival free disease years months direct disease-specific survival free disease patients years undetectable levels prostate specific antigen Cox univariate proportional hazards several factors significant prognostic value volume lymph node metastases macroscopic mm percentage positive lymph nodes frozen section diagnosis Gleason grade clinical stage number positive nodes significant prognostic value Local recurrence operation patients radiotherapy radical prostatectomy Significant gastrointestinal genitourinary complications men radiotherapy undergoing radical prostatectomy introduction nerve-sparing radical prostatectomy potency patients potent year data patients radical prostatectomy curative excellent palliation local lesion acceptable morbidity symptomatic local recurrence prostatic cancer radiation therapy identical results men